Pharmacological treatment for unipolar psychotic depression
- 1 May 2006
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 188 (5), 410-415
- https://doi.org/10.1192/bjp.bp.105.010470
Abstract
Background The optimal pharmacological treatment of unipolar psychotic depression is uncertain.Keywords
This publication has 14 references indexed in Scilit:
- Pharmacological treatment for psychotic depressionPublished by Wiley ,2005
- A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatientsPsychopharmacology, 2004
- Venlafaxine Versus Fluvoxamine in the Treatment of Delusional DepressionThe Journal of Clinical Psychiatry, 2000
- Psychotic DepressionCNS Drugs, 1997
- A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patientsPsychopharmacology, 1996
- A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patientsPsychopharmacology, 1996
- Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1993
- Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depressionAmerican Journal of Psychiatry, 1990
- Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1990
- Placebo response rates in psychotic and nonpsychotic depressionJournal of Affective Disorders, 1988